WORCESTER, Mass. -- Compounds in cranberry juice have the ability to change E. coli bacteria, a class of microorganisms responsible for a host of human illnesses (everything from kidney infections to gastroenteritis to tooth decay), in ways that render them unable to initiate an infection. The results of this new research by scientists at Worcester Polytechnic Institute (WPI) suggest that the cranberry may provide an alternative to antibiotics, particularly for combating E. coli bacteria that have become resistant to conventional treatment.
The new findings, which were presented Sunday at the annual meeting of the American Chemical Society in San Francisco, for the first time begin to paint a detailed picture of the biochemical mechanisms that may underlie a number of beneficial health effects of cranberry juice that have been reported in other studies over the years.
Many of those studies have focused on the ability of cranberry juice to prevent urinary tract infections (UTIs), which each year affect 8 million people -- mostly women, the elderly, and infants -- resulting in $1.6 billion in healthcare costs. Until now, scientists have not understood exactly how cranberry juice prevents UTIs and other bacterial infections, though they have suspected that compounds in the juice somehow prevent bacteria from adhering to the lining of the urinary tract. The new findings reveal how the compounds interfere with adhesion at the molecular level.
The research, by Terri Camesano, associate professor of chemical engineering at WPI, and graduate students Yatao Liu and Paola Pinzon-Arango, and funded, in part, by the National Science Foundation, shows that a group of tannins (called proanthocyanidins) found primarily in cranberries affect E. coli in three devastating ways, all of which prevent the bacteria from adhering to cells in the body, a necessary first step in all infections:
-- They change the shape of the bacteria from rods to spheres.
-- They alter their cell membranes.
-- They make it difficult for bacteria to make contact with cells, or from latching on to them should they get close enough.
For most of these effects, the impact on bacteria was stronger the higher the concentration of either cranberry juice or the tannins, suggesting that whole cranberry products and juice that has not been highly diluted may have the greatest health effects.
The new results build on previously published work, in which Camesano and her team showed that cranberry juice causes tiny tendrils (known as fimbriae) on the surface of the type of E. coli bacteria responsible for the most serious types of UTIs to become compressed. Since the fimbriae make it possible for the bacteria to bind tightly to the lining of the urinary tract, the change in shape greatly reduces the ability of the bacteria to stay put long enough to initiate an infection.
More recently, Camesano and Liu have shown that chemical changes caused by cranberry juice also create an energy barrier that keeps the bacteria from getting close to the urinary tract lining in the first place.
New work by Camesano and Pinzon-Arango shows that cranberry juice can transform E. coli bacteria in even more radical ways. The researchers grew E. coli over extended periods in solutions containing various concentrations of either cranberry juice or tannins. Over time, the normally rod-shaped bacteria became spherical -- a transformation that has never before been observed in E. coli.
Remarkably, the E. coli bacteria, all of which fall into a class called gram-negative bacteria, began behaving like gram-positive bacteria -- another never-before-seen phenomenon. Since gram-negative and gram-positive bacteria differ primarily in the structure of their cell membranes, the results suggest that the tannins in cranberry juice can alter the membranes of E. coli.
A final, more preliminary result that will be presented at the ACS meeting suggests that E. coli bacteria exposed to cranberry juice appear to lose the ability to secrete indole, a molecule involved in a form of bacterial communication called quorum sensing. E. coli use quorum sensing to determine when there are enough bacteria present at a certain location to initiate a successful infection.
"We are beginning to get a picture of cranberry juice and, in particular, the tannins found in cranberries as, potentially potent antibacterial agents," Camesano says. "These results are surprising and intriguing, particularly given the increasing concern about the growing resistance of certain disease-causing bacteria to antibiotics."
Source: Worcester Polytechnic Institute
Â
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.